oncodesign.com rapport :   Visitez le site

Données techniques du oncodesign.com

Geo IP vous fournit comme la latitude, la longitude et l'ISP (Internet Service Provider) etc. informations. Notre service GeoIP a trouvé l'hôte oncodesign.com.Actuellement, hébergé dans Italy et son fournisseur de services est IUNET BNET .

the related websites

domaine	Titre
oncology.pub	oncology.pub - the latest clinical oncology news & research
oncodesign.com	oncodesign – biopharmaceutical company – oncology and non-oncology
oncodesign.fr	oncodesign – biopharmaceutical company – oncology and non-oncology
codes.iarc.fr	international classification of diseases for oncology
advmodoncolres.com	advances in modern oncology research
theonc.org	home | theonc | a gated community for oncology nurses and cancer care teams

boursorama.com boursier.com abcbourse.com kellyservices.fr capital.fr caducee.net informationhospitaliere.com zonebourse.com gala.fr fournaise.info phdn.org amourmaghreb.com frandroid.com pcastuces.com chevauchonde.net asgestionconseil.com free.fr 

Analyse d'en-tête HTTP

Les informations d'en-tête HTTP font partie du protocole HTTP que le navigateur d'un utilisateur envoie à appelé Apache contenant les détails de ce que le navigateur veut et acceptera de nouveau du serveur Web.

DNS

HtmlToText

-- -- fr en jp news careers contact us menu about offerings innovation model technologies investors [press release] oncodesign: very strong revenue growth of 58% to €9.2 million in the first half of 2018 - service revenue up 63.2% to €8.7 million, including robust momentum in the north american business (growth of 254%) - teams from the françois hyafil research center and bertin pharma’s service activities successfully integrated read the press release discover innovative new therapies against cancer and serious illnesses with unmet medical needs access our innovation platform via three offerings: as a service , under a partnership or based on a licensing arrangement discover our offerings our unique, patient-centered innovation model thanks to its precision medicine platform, oncodesign is able to orient at a very early stage its research and the development of innovative therapeutic solutions for resistant and unresponsive diseases explore our model a continuum of technologies from the molecule to the patient for over 20 years, oncodesign has invested in translational research technologies to bring valuable innovation into the initial phases of the drug discovery process. discover our technologies about oncodesign read our vision management introduce our management key figures see our figures discover our sab discover our mission oncodesign in the world find us offerings service starting out from your targets or your molecules, we design and select the best drug candidates idds (integrated drug discovery services) proof of concept - pharmacology dmpk bioanalysis biobanking translational biomarkers biodecontamination / biosafety partnership use our development programs at a very early stage by entering into a long-term strategic partnership kinase inhibitor development programs technology partnership licensing license technologies, drug candidates and radiotracers from oncodesign’s portfolio kinase inhibitors in oncology, cns and inflammation technologies therapeutic areas & experimental models our innovation model etiology knowledge: identifying is a big step towards solving puzzles discovery investigation: the quest for efficacy experimentation potential: formulate new treatments technologies nanocyclix® the power and selectivity of nanocyclix® molecules applied to the entire kinome. learn more t.o.t® streamline the choice of therapeutic orientation for your projects by qualifying in vitro the potential of your molecules and your targets. learn more predict® select the best drug candidates and their biomarkers by harnessing our pharmacological expertise. learn more chi-mice® use our humanized models to reproduce the targeted pathology effectively: pdx, in vivo humanization of tissues from human stem cells (liver, immune system, skin, stroma, etc.). learn more pharmimage® integrate our multi-modal pharmaco-imaging expertise with your preclinical and clinical projects. learn more oncosnipe® set the direction at a very early stage for the research and development of therapeutic solutions for resistant and unresponsive patients. learn more oncodesign news [congress] discovery on target – 25-28 september – boston - usa interested in next generation of kinase inhibitors, integrated drug discovery partner or services using our technological platforms? learn more [congress] europdx workshop - 1-3 october 2018 - weggis - switzerland join caroline mignard at the europdx workshop for great talks and discussions on all aspects of patient-derived xenograft tumor research! learn more [congress] eanm' - 13-17 october 2018 - düsseldorf - germany the eanm annual meeting is the leading conference to network and discuss the newest trends and findings in the field of nuclear medicine. learn more [press release] oncodesign furthers its cooperation with eisai, started 12 years ago 06/09/2018 learn more see all news investors financial calendar stock price documentation press releases subscribe to the investor alert investors contacts word from the chairman since our april 2014 ipo, we have accelerated our development and have become an international biopharma company specialized in precision medicine pursuing ambitious development objectives underpinned by acquisition-led growth and investments in innovative therapeutic research programs. learn more careers oncodesign’s mission is to discover innovative new therapies effective against cancer and serious illnesses with unmet medical needs. oncodesign has opted to take the time to build up all the dimensions of its organization—scientific, technical, business, starting with the most crucial one, the human dimension . our values job offers/work-study arrangements internship available spontaneous applications contact us select a service (*) sales & marketing bu finance & shareholders relationship bu press relation bu administrative bu human resources bu invalid input (*) invalid input (*) invalid input (*) please write a subject for your message. (*) please let us know your message. send sales team if you have any questions, please contact the member of our sales team responsible for your geographical region, and we will get back to you as swiftly as we can. connect with us now about oncodesign vision our mission key figures management scientific advisory board where to find us offerings services partnerships licensing therapeutic areas & experimental models our innovation model etiology discovery experimentation our technologies nanocyclix® t.o.t.® predict® chi-mice® pharmimage® oncosnipe® investors a word from the chairman financial calendar shares documentation sign up for email alerts investors contacts carreers our values job offers/work-study arrangements internships spontaneous applications news upcoming events webinars scientific publications contact contact us sales team cookies legal notice contact us (c) copyright oncodesign - all right reserved 20 rue jean mazen | b.p. 27627 | 21076 dijon cedex | france | tel.+33 (0)3.80.78.82.60 | fax +33 (0)3.80.78.82.61 newsletter- en subscribe to the general newsletter (*) invalid input (*) invalid input sign-up subscribe to the investor alert by closing this message, you consent to our cookies on this device in accordance with our cookie policy unless you have disabled them. i agree! learn more

Analyse PopURL pour oncodesign.com

https://www.oncodesign.com/en/en/news-oncodesign/1100-oncodesign-furthers-its-cooperation-with-eisai-started-12-years-ago
https://www.oncodesign.com/en/#actualites
https://www.oncodesign.com/en/en/our-technologies/tot-technology
https://www.oncodesign.com/en/en/our-philosophy
https://www.oncodesign.com/en/en/sign-up-for-e-alert
https://www.oncodesign.com/en/en/financial-calendar
https://www.oncodesign.com/en/en/about-oncodesign/where-to-find-us
https://www.oncodesign.com/en/en/contact-us
https://www.oncodesign.com/en/en/about-oncodesign/management
https://www.oncodesign.com/en/en/about-oncodesign/scientific-advisory-board
https://www.oncodesign.com/en/en/our-technologies/pharmimage-technology
https://www.oncodesign.com/en/#investisseurs
https://www.oncodesign.com/en/en/about-oncodesign/our-mission
https://www.oncodesign.com/en/en/offerings
https://www.oncodesign.com/en/en/our-innovation-model-en
afssi.fr

Informations Whois

Whois est un protocole qui permet d'accéder aux informations d'enregistrement.Vous pouvez atteindre quand le site Web a été enregistré, quand il va expirer, quelles sont les coordonnées du site avec les informations suivantes. En un mot, il comprend ces informations;

Domain Name: oncodesign.com
Registry Domain ID: 78846389_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.oleane.net
Registrar URL: http://cloud.orange-business.com/noms-de-domaine
Updated Date: 2013-10-28T00:00:00Z
Creation Date: 2001-10-22T00:00:00Z
Registrar Registration Expiration Date: 2020-04-22T04:00:00Z
Registrar: ORANGE
Registrar IANA ID: 14
Registrar Abuse Contact Email: abuse-registrar@orange-business.com
Registrar Abuse Contact Phone: +33.170480020
Reseller:
Domain Status: OK - http://www.icann.org/epp#OK
Registry Registrant ID:
Registrant Name: CATHERINE GENNE
Registrant Organization: ONCODESIGN
Registrant Street: 20 RUE JEAN MAZEN
Registrant City: DIJON
Registrant State/Province:
Registrant Postal Code: 21000
Registrant Country: FR
Registrant Phone:
Registrant Phone Ext:
Registrant Fax:
Registrant Fax Ext:
Registrant Email: cgenne@oncodesign.fr
Registry Admin ID:
Admin Name: CATHERINE GENNE
Admin Organization: ONCODESIGN
Admin Street: 28 Rue De Broglie
Admin City: DIJON
Admin State/Province:
Admin Postal Code: 21000
Admin Country: FR
Admin Phone: +33 380788260
Admin Phone Ext:
Admin Fax: +33 380788261
Admin Fax Ext:
Admin Email: cgenne@oncodesign.fr
Registry Tech ID:
Tech Name: CATHERINE GENNE
Tech Organization: ONCODESIGN
Tech Street: 28 Rue De Broglie
Tech City: DIJON
Tech State/Province:
Tech Postal Code: 21000
Tech Country: FR
Tech Phone: +33 380788260
Tech Phone Ext:
Tech Fax: +33 380788261
Tech Fax Ext:
Tech Email: cgenne@oncodesign.fr
Registry Billing ID:
Billing Name: Sylvain DUFIER
Billing Organization: Orange SA
Billing Street: 13 rue de Javel
Billing City: PARIS
Billing State/Province:
Billing Postal Code: 75015
Billing Country: FR
Billing Phone: +33 153951400
Billing Phone Ext:
Billing Fax: +33 153951401
Billing Fax Ext:
Billing Email: domaine-admin@list.orange-ftgroup.com
Name Server: NS2.OLEANE.NET
Name Server: NS3.OLEANE.NET
DNSSEC: unsigned
URL of the ICANN WHOIS Data Problem Reporting System:
http://wdprs.internic.net/
>>> Last update of WHOIS database: 2017-07-05T16:05:04Z <<<

"For more information on Whois status codes, please visit https://www.icann.org/resources/pages/epp-status-codes-2014-06-16-en."


% Database of ".com", ".net" domains registered by
% Orange.
%
% Access and use restricted pursuant to french law on personal data.
%
% The data in this record is provided for informational purposes only as
% communicated by the Domain Name Owner, and Orange does not
% guarantee its accuracy.
%
% You agree that you will use this data only for lawful purposes and that,
% under no circumstances will you use this data to allow, enable or
% otherwise support any marketing activities, regardless of the medium
% used. Such media include but are not limited to e-mail, facsimile,
% postal mail, SMS and wireless alerts.
%
% You will not either sell or redistribute the data except insofar as
% it has been incorporated by yourself into a value-added product or
% service that does not permit the extraction of a substantial portion of
% the bulk data from the value-added product or service for use by other
% parties.
%
%
% Base de donnees des domaines ".com", ".net" enregistres
% par le Bureau d'Enregistrement ORANGE.
%
% Acces et utilisation soumis a la legislation francaise sur les donnees
% personnelles.
%
% Ce service est fourni uniquement a titre indicatif d'apres les
% declarations du titulaire du nom de domaine et Orange n'en
% garantit pas l'exactitude.
%
% Vous acceptez de n'utiliser ces informations qu'a des fins
% strictement legales et ne pourrez en permettre, faciliter ou encourager
% en aucune maniere tout usage marketing, quel que soit le support utilise.
% De tels supports comprennent, sans s'y limiter : l'Email, le telephone,
% le FAX, le courrier postal, les SMS ou autres notifications sans fil, etc
%
% Vous n'etes pas non plus autorise a vendre ou redistribuer les
% donnees, sauf dans le cas ou vous les avez incorporees dans un produit
% ou service a valeur ajoutee qui interdise toute extraction substantielle
% a fins d'utilisation par des tiers.


  REGISTRAR ORANGE

  REFERRER http://www.hebergementweb.orange-business.com/noms-de-domaine

SERVERS

  SERVER com.whois-servers.net

  ARGS domain =oncodesign.com

  PORT 43

  SERVER whois.oleane.net

  ARGS oncodesign.com

  PORT 43

  TYPE domain
RegrInfo
DOMAIN

  NAME oncodesign.com

NSERVER

  NS2.OLEANE.NET 194.2.0.2

  NS3.OLEANE.NET 194.250.249.14

STATUS
ok https://icann.org/epp#ok

  CHANGED 2016-10-23

  CREATED 2001-10-22

  EXPIRES 2017-10-22

  REGISTERED yes

Erreurs

La liste suivante vous montre les fautes d'orthographe possibles des internautes pour le site Web recherché.